The New England Journal of Medicine, 376, 16, pp. 1527-1539 New England Journal of Medicine New England Journal of Medicine, Massachusetts Medical Society, 2017, 376 (16), pp.1527-1539. ⟨10.1056/NEJMoa1701488⟩ New England Journal of Medicine, 376(16), 1527-1539. MASSACHUSETTS MEDICAL SOCIETY New England Journal of Medicine, 376(16), 1527. Massachussetts Medical Society The New England Journal of Medicine, 376, 1527-1539 Department of Medicine Publications Ridker, P M, Revkin, J, Amarenco, P, Brunell, R, Curto, M, Civeira, F, Flather, M, Glynn, R J, Gregoire, J, Jukema, J W, Karpov, Y, Kastelein, J J P, Koenig, W, Lorenzatti, A, Manga, P, Masiukiewicz, U, Miller, M, Mosterd, A, Murin, J, Nicolau, J C, Nissen, S, Ponikowski, P, Santos, R D, Schwartz, P F, Soran, H, White, H, Wright, R S, Vrablik, M, Yunis, C, Shear, C L, Tardif, J-C, SPIRE Cardiovascular Outcome Investigators & Michael Jepsen, J 2017, ' Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients ', The New England Journal of Medicine, vol. 376, no. 16, pp. 1527-1539 . https://doi.org/10.1056/NEJMoa1701488 New England Journal of Medicine, 376(16), 1527-1539 Zaguán. Repositorio Digital de la Universidad de Zaragoza instname New England journal of medicine, 376(16), 1527-1539. Massachussetts Medical Society